S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Syneos Health Stock Forecast, Price & News

-0.11 (-0.15%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
420,301 shs
Average Volume
574,242 shs
Market Capitalization
$7.34 billion
P/E Ratio
Dividend Yield
Price Target

Syneos Health Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.78 Rating Score
38.0% Upside
$98.78 Price Target
Short Interest
1.95% of Float Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
1.54mentions of Syneos Health in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$14.87 K Sold Last Quarter
Proj. Earnings Growth
From $4.64 to $5.24 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.76 out of 5 stars

Medical Sector

25th out of 1,428 stocks

Commercial Physical Research Industry

1st out of 24 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

Syneos Health logo

About Syneos Health (NASDAQ:SYNH)

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

SYNH Stock News Headlines

Syneos Health (NASDAQ:SYNH) Reaches New 1-Year Low at $64.77
Syneos Health Leaders Recognized by HBA
Syneos Health Reports First Quarter 2022 Results
A Preview Of Syneos Health's Earnings
Syneos Health Q1 2022 Earnings Preview
Jefferies Downgrades Syneos Health to Hold
See More Headlines

Industry, Sector and Symbol

Commercial physical research
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
9 Analysts


Net Income
$234.83 million
Pretax Margin


Sales & Book Value

Annual Sales
$5.21 billion
Cash Flow
$6.29 per share
Book Value
$32.91 per share


Free Float
Market Cap
$7.34 billion

Syneos Health Frequently Asked Questions

Should I buy or sell Syneos Health stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Syneos Health stock.
View analyst ratings for Syneos Health
or view top-rated stocks.

What is Syneos Health's stock price forecast for 2022?

9 Wall Street analysts have issued twelve-month price targets for Syneos Health's shares. Their SYNH stock forecasts range from $75.00 to $122.00. On average, they anticipate Syneos Health's share price to reach $98.78 in the next twelve months. This suggests a possible upside of 38.0% from the stock's current price.
View analysts' price targets for Syneos Health
or view top-rated stocks among Wall Street analysts.

How has Syneos Health's stock price performed in 2022?

Syneos Health's stock was trading at $102.68 at the start of the year. Since then, SYNH shares have decreased by 30.3% and is now trading at $71.57.
View the best growth stocks for 2022 here

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Syneos Health

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) issued its quarterly earnings results on Friday, April, 29th. The company reported $0.89 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.05. The business had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.32 billion. Syneos Health had a trailing twelve-month return on equity of 13.33% and a net margin of 4.54%. The company's revenue for the quarter was up 10.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.66 earnings per share.
View Syneos Health's earnings history

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $5.05-$5.25 for the period, compared to the consensus EPS estimate of $5.08. The company issued revenue guidance of $5.60 billion-$5.75 billion, compared to the consensus revenue estimate of $5.65 billion.

Who are Syneos Health's key executives?

Syneos Health's management team includes the following people:

What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health CEO Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among Syneos Health's employees.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Square (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $71.57.

How much money does Syneos Health make?

Syneos Health (NASDAQ:SYNH) has a market capitalization of $7.34 billion and generates $5.21 billion in revenue each year. The company earns $234.83 million in net income (profit) each year or $2.31 on an earnings per share basis.

How many employees does Syneos Health have?

Syneos Health employs 28,000 workers across the globe.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for Syneos Health is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360.

This page (NASDAQ:SYNH) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.